Literature DB >> 22239894

Imaging of receptors for advanced glycation end products in experimental myocardial ischemia and reperfusion injury.

Yared Tekabe1, Joane Luma, Qing Li, Ann Marie Schmidt, Ravichandran Ramasamy, Lynne L Johnson.   

Abstract

OBJECTIVES: The aim of this study was to image expression of receptor for advanced glycation end products (RAGE) in a mouse model of myocardial reperfusion injury.
BACKGROUND: RAGE and its ligands are implicated in the pathogenesis of ischemia/reperfusion injury and infarction. We hypothesized that RAGE-directed quantitative imaging of myocardial uptake of technetium-99m ((99m)Tc)-anti-RAGE F(ab')(2) in a mouse model of myocardial ischemic injury can detect RAGE expression and show quantitative differences between early (18 to 20 h) and later times (48 h) after reperfusion.
METHODS: Twenty-five wild-type (WT) mice underwent left anterior descending coronary artery occlusion for 30 min. Mice were injected with 19.98 ± 1.78 MBq of (99m)Tc anti-RAGE F(ab')(2) at 2 time points after reperfusion (at 18 to 20 h [n = 8] and at 48 h [n = 12]) and 5 h later with 6.14 ± 2.0 MBq of thallium-201 ((201)Tl). Five WT mice were injected with nonspecific F(ab')(2) and (201)Tl 18 to 20 h after reperfusion. Six WT mice underwent sham operation without coronary intervention. After injection with (201)Tl, all mice immediately underwent dual isotope single-photon emission computed tomography/computed tomography. At completion of imaging, hearts were counted and sectioned.
RESULTS: The uptake of (99m)Tc-anti-RAGE F(ab')(2) in the ischemic zone from the scans as mean percentage injected dose was significantly greater at 18 to 20 h (5.7 ± 2.1 × 10(-3)%) as compared with at 48 h (1.4 ± 1.1 × 10(-3)%; p < 0.001) after reperfusion. Disease and antibody controls showed no focal uptake in the infarct. Gamma well counting of the myocardium supported the quantitative scan data. By immunohistochemical staining there was greater caspase-3 and RAGE staining at 18 to 20 h versus at 48 h (p = 0.04 and p = 0.01, respectively). On dual immunofluorescence, RAGE colocalized mainly with injured cardiomyocytes undergoing apoptosis.
CONCLUSIONS: RAGE expression in myocardial ischemic injury can be imaged in vivo using a novel (99m)Tc-anti-RAGE F(ab')(2). RAGE plays a role in several cardiovascular diseases and is a potential target for clinical imaging.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22239894      PMCID: PMC3636550          DOI: 10.1016/j.jcmg.2011.09.016

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  17 in total

1.  RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

Authors:  M A Hofmann; S Drury; C Fu; W Qu; A Taguchi; Y Lu; C Avila; N Kambham; A Bierhaus; P Nawroth; M F Neurath; T Slattery; D Beach; J McClary; M Nagashima; J Morser; D Stern; A M Schmidt
Journal:  Cell       Date:  1999-06-25       Impact factor: 41.582

2.  Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins.

Authors:  M Neeper; A M Schmidt; J Brett; S D Yan; F Wang; Y C Pan; K Elliston; D Stern; A Shaw
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

3.  S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE).

Authors:  Thiruvengadam Arumugam; Diane M Simeone; Ann Marie Schmidt; Craig D Logsdon
Journal:  J Biol Chem       Date:  2003-11-14       Impact factor: 5.157

4.  Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.

Authors:  J Brett; A M Schmidt; S D Yan; Y S Zou; E Weidman; D Pinsky; R Nowygrod; M Neeper; C Przysiecki; A Shaw
Journal:  Am J Pathol       Date:  1993-12       Impact factor: 4.307

5.  A novel monoclonal antibody for RAGE-directed imaging identifies accelerated atherosclerosis in diabetes.

Authors:  Yared Tekabe; Joane Luma; Andrew J Einstein; Marija Sedlar; Qing Li; Ann Marie Schmidt; Lynne L Johnson
Journal:  J Nucl Med       Date:  2009-12-15       Impact factor: 10.057

6.  RAGE modulates hypoxia/reoxygenation injury in adult murine cardiomyocytes via JNK and GSK-3beta signaling pathways.

Authors:  Linshan Shang; Radha Ananthakrishnan; Qing Li; Nosirudeen Quadri; Mariane Abdillahi; Zhengbin Zhu; Wu Qu; Rosa Rosario; Fatouma Touré; Shi Fang Yan; Ann Marie Schmidt; Ravichandran Ramasamy
Journal:  PLoS One       Date:  2010-04-09       Impact factor: 3.240

7.  Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age.

Authors:  Jörg J Jacoby; April Kalinowski; Mu-Gen Liu; Samuel S-M Zhang; Qian Gao; Gui-Xuan Chai; Lan Ji; Yoshiki Iwamoto; En Li; Michael Schneider; Kerry S Russell; Xin-Yuan Fu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

8.  Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins.

Authors:  A M Schmidt; M Hasu; D Popov; J H Zhang; J Chen; S D Yan; J Brett; R Cao; K Kuwabara; G Costache
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

9.  Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice.

Authors:  Shan Zeng; Nikki Feirt; Michael Goldstein; James Guarrera; Nikalesh Ippagunta; Udeme Ekong; Hao Dun; Yan Lu; Wu Qu; Ann Marie Schmidt; Jean C Emond
Journal:  Hepatology       Date:  2004-02       Impact factor: 17.425

10.  Development of receptor for advanced glycation end products-directed imaging of atherosclerotic plaque in a murine model of spontaneous atherosclerosis.

Authors:  Yared Tekabe; Qing Li; Rosa Rosario; Marija Sedlar; Stan Majewski; Barry I Hudson; Andrew J Einstein; Ann Marie Schmidt; Lynne L Johnson
Journal:  Circ Cardiovasc Imaging       Date:  2008-11       Impact factor: 7.792

View more
  5 in total

1.  Quantitative imaging of the receptor for advanced glycation end-products in prostate cancer.

Authors:  Christian J Konopka; Marcin Woźniak; Jamila Hedhli; Anna Siekierzycka; Jarosław Skokowski; Rafał Pęksa; Marcin Matuszewski; Gnanasekar Munirathinam; Andre Kajdacsy-Balla; Iwona T Dobrucki; Leszek Kalinowski; Lawrence W Dobrucki
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-03-12       Impact factor: 9.236

Review 2.  Therapeutic potential of vitamin D in AGE/RAGE-related cardiovascular diseases.

Authors:  Ting-Wei Lee; Yu-Hsun Kao; Yi-Jen Chen; Tze-Fan Chao; Ting-I Lee
Journal:  Cell Mol Life Sci       Date:  2019-06-27       Impact factor: 9.261

3.  Advanced glycated end-products affect HIF-transcriptional activity in renal cells.

Authors:  Tzvetanka Bondeva; Juliane Heinzig; Carola Ruhe; Gunter Wolf
Journal:  Mol Endocrinol       Date:  2013-09-12

4.  Single-photon emission computed tomography/computed tomography imaging of RAGE in smoking-induced lung injury.

Authors:  Monica P Goldklang; Yared Tekabe; Tina Zelonina; Jordis Trischler; Rui Xiao; Kyle Stearns; Krissy Rodriguez; Alexander Shields; Alexander Romanov; Jeanine M D'Armiento; Lynne L Johnson
Journal:  Respir Res       Date:  2019-06-10

Review 5.  Soluble Receptor for Advanced Glycation End Product: A Biomarker for Acute Coronary Syndrome.

Authors:  Louise J N Jensen; Allan Flyvbjerg; Mette Bjerre
Journal:  Biomed Res Int       Date:  2015-09-30       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.